Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anemia, Refractory, with Excess of Blasts × entinostat × 90 days × Clear all

Sponsor

Conditions

Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Recurrence 1 Penile Neoplasms 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neuroendocrine Tumors 1 Head and Neck Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Anus Neoplasms 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Cyclophosphamide 6 fludarabine 5 Mycophenolic Acid 5 Azacitidine 5 Whole-Body Irradiation 4 Tacrolimus 4 venetoclax 3 fludarabine phosphate 3 decitabine and cedazuridine drug combination 2 Vorinostat 2 Specimen Handling 2 Melphalan 2 Granulocyte Colony-Stimulating Factor 2 Busulfan 2 Biopsy 2 sulforaphane 1 ruxolitinib 1 enasidenib 1 cedazuridine 1 Triamcinolone 1 TAK-243 1 Stem Cell Transplantation 1 Sirolimus 1 Peripheral Blood Stem Cell Transplantation 1 Mesna 1 Lenalidomide 1 Hematopoietic Stem Cell Transplantation 1 Filgrastim 1 Cyclosporins 1 Cyclosporine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡